SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

SMTL ID : 4eev.1

Crystal structure of c-Met in complex with LY2801653

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.80 Å
Oligo State
monomer
Ligands
1 x L1X: N-(3-fluoro-4-{[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy}phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Yan, S.B. et al., LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models. Invest New Drugs (2013)
Release Date
2013-04-10
Peptides
Hepatocyte growth factor receptor: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Hepatocyte growth factor receptor